What is the difference between isolate, broad-spectrum, and full-spectrum CBD?

Isolate is pure CBD with no THC; broad-spectrum includes multiple cannabinoids without THC; full-spectrum includes the full plant profile with up to 0.3% THC.

Is your CBD THC-free?

Our isolate and broad-spectrum products are THC-free. Product pages and labels list exact cannabinoid content.

How do I take CBD oil?

Most people place the oil under the tongue for 60-90 seconds before swallowing; start low and adjust gradually.

Hemp-derived CBD is federally legal under the 2018 Farm Bill; check your local regulations.

How do I place an order?

Choose a product above and tap Order, or email info@biomedrxmedicalmarijuana.com and we'll confirm your order by email.

BiomedRx Medical Marijuana | California Patient Education & Resources

Medical cannabis access and education.

Based in Upland, California, BiomedRx Medical Marijuana provides Health & Safety Code-compliant 215 recommendations, CBD and cannabis patient education, strain consultation, and dedicated programs for seniors and veterans. We do not sell, possess, or distribute cannabis — we guide compliant access.

Educational

California Senate Bill 47: How Medical Cannabis Patient Protections Strengthened in 2026

California continues to refine how it protects medical cannabis patients under the framework established by the Compassionate Use Act and the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA). Proposals in this space generally aim to clarify the rights of qualified patients, tighten confidentiality around the state's voluntary Medical Marijuana Identification Card program, and confirm the role of designated primary caregivers who may cultivate or transport medicine on a patient's behalf.

The practical effect for patients typically centers on a physician recommendation rather than a prescription, since cannabis remains federally controlled and is not an FDA-approved medication. Patients considering medical cannabis should talk with a licensed healthcare provider about their specific condition, current medications, and possible interactions before starting or changing any regimen. Cannabis products are not approved by the FDA to diagnose, treat, cure, or prevent any disease, and individual results and legal protections can vary by county.

Because state law changes frequently and enforcement details can differ locally, patients and caregivers should verify current requirements with official California sources rather than relying on summaries alone.

Sources: FDA — Regulation of Cannabis-Derived Products; NIDA — Cannabis (Marijuana)

Apr 24, 202617 min read

Informative

DEA's 2026 Schedule III Implementation Update — What Patients Need to Know

In 2024 the U.S. Department of Justice issued a proposed rule to move cannabis from Schedule I to Schedule III of the Controlled Substances Act, following a recommendation from the Department of Health and Human Services. Rescheduling would formally recognize a currently accepted medical use and a lower potential for abuse relative to Schedule I substances, but the process involves administrative review and has not automatically legalized cannabis at the federal level. The status and timing of any final action can change, so patients should treat implementation dates cautiously.

A move to Schedule III could ease some barriers to research and affect how cannabis businesses are taxed, but it would not by itself make state-authorized cannabis products FDA-approved medicines, nor would it eliminate the differences between federal and California law. For most California patients, day-to-day access continues to operate under state rules rather than federal prescribing pathways.

Anyone weighing medical cannabis should consult a licensed healthcare provider about risks, benefits, and interactions. Cannabis is not FDA-approved to diagnose, treat, cure, or prevent any disease.

Sources: FDA — Cannabis Regulation; NIDA — Cannabis (Marijuana)

Apr 20, 202611 min read

Field Notes

We Helped 240 Senior Patients Navigate Their First Recommendation Last Year. The Most Common Question.

Older adults are among the fastest-growing groups exploring cannabis, often for chronic pain, sleep difficulties, or symptoms related to other conditions. In our experience the most common questions are about legality and about which products might help, but the more important conversation is usually about safety. Seniors frequently take multiple medications, and cannabis, including THC and CBD, can interact with blood thinners, sedatives, and other drugs, and may increase the risk of dizziness or falls.

The current evidence for cannabis and cannabinoids is mixed. Reviews by the National Academies and NIH note some support for cannabis in managing certain types of chronic pain in adults, while evidence for many other uses remains limited or preliminary. Effects depend heavily on the product, dose, and the individual, so starting low and going slow under professional guidance is prudent.

We do not make medical promises. Anyone, especially older adults, should consult their physician or pharmacist before trying cannabis. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease.

Sources: NIH NCCIH — Cannabis and Cannabinoids; NIDA — Cannabis (Marijuana)

Apr 13, 20266 min read

Explore your options.

Tell us about your condition or concerns. We'll explain how medical cannabis may fit into your health plan and what the process looks like.

All services comply with California Health and Safety Code §11362.5 and §11362.7. BiomedRx does not sell, possess, or distribute cannabis. We provide compliant access guidance and patient education only.